Promore Pharma
Research - Solna, Stockholm County, Sweden
Promore Pharma Employees
Promore Pharma Senior Management
Promore Pharma Details
Promore Pharma is a biopharmaceutical company specialized in the development of therapeutic peptides. The company's aim is to develop first-in-category pharmaceuticals for indications with high unmet medical needs, where very few efficacious prescription pharmaceuticals are available. Promore Pharma's two projects are undergoing clinical development and have a very strong safety profile since the products are based on endogeneous substances that are administered locally. The leading project, ensereptide (PXL01), that will be used for prevention of post-surgical scarring, is being prepared for a clinical Phase II-trial if the peptide can prevent the formation of unesthetical scars on the skin. Ropocamptide (LL-37) has recently been evaluated in a clinical phase IIb study with positive results in patients with venous leg ulcers (VLUs). The product candidates can also be deployed for other indications, such as preventing unfavorable tissue attachments (adhesions) after different kinds of surgical procedures and treatment of diabetic foot ulcers. The company is listed on the Nasdaq First North Growth Market (ticker "PROMO").
Promore Pharma Technologies
Retargeting
Facebook Custom Audiences
Email Providers
Outlook
Social Sharing
AddThis
Social Login
Facebook Login (Connect)
Web Presentation Tools
GoToWebinar
Other
Microsoft Office 365